Suppressive effect of the herbal medicine Oren-gedoku-to on cyclooxygenase-2 activity and azoxymethane-induced aberrant crypt foci development in rats

Cancer Letters

Volumn 157, Issue 1, 2000, Pages 9-14

  Fukutake, Masato ^a   Miura, Naoko ^a   Yamamoto, Masahiro ^a   Fukuda, Kazunori ^c   Iijima, Osamu ^a   Ishikawa, Hiroki ^a   Kubo, Masayoshi ^a   Okada, Minoru ^a   Komatsu, Yasuhiro ^a   Sasaki, Hiroshi ^a   Wakabayashi, Keiji ^b   Ishige, Atsushi ^a   Amagaya, Sakae ^a  

^a TSUMURA AND CO   (Japan)

^b NATIONAL CANCER CENTER   (Japan)

^c GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aberrant crypt foci; Chemoprevention; Cyclooxygenase 2; Herbal medicine; Oren gedoku to

Indexed keywords

AZOXYMETHANE; CYCLOOXYGENASE 2; ORENGEDOKU TO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOPROPHYLAXIS; COLON CANCER; CONTROLLED STUDY; ENZYME INHIBITION; HERB; HERBAL MEDICINE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTICARCINOGENIC AGENTS; AZOXYMETHANE; CARCINOGENS; COLONIC NEOPLASMS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DRUGS, CHINESE HERBAL; ISOENZYMES; MALE; MEMBRANE PROTEINS; PLANT EXTRACTS; PRECANCEROUS CONDITIONS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, INBRED F344;

COPTIDIS; COPTIDIS RHIZOMA; FRUCTUS; GARDENIAE; GARDENIAE FRUCTUS; RHIZOMA; SCUTELLARIAE; SCUTELLARIAE RADIX;

EID: 0034739320     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00432-8     Document Type: Article

References (34)

1. Thun M.J., Calle E.E., Namboodiri M.M., Flanders W.D., Coates R.J., Byers T., Boffetta P., Garfinkel L., Heath C.W. Jr. Risk factors for fatal colon cancer in a large prospective study. J. Natl. Cancer Inst. 84:1992;1491-1500.
2. Ames B.N., Gold L.S., Willett W.C. The cause and prevention of cancer. Proc. Natl. Acad. Sci. USA. 92:1995;5258-5265.
3. Alabaster O., Tang Z.C., Frost A., Shivapurkar N. Effect of β-carotene and wheat bran fiber on colonic aberrant crypt and tumor formation in rats exposed to azoxymethane and high dietary fat. Carcinogenesis. 16:1995;127-132.
4. Wattenberg L.W. Inhibition of carcinogenesis by minor dietary constituents. Cancer Res. 52:1992;2085s-2091s.
5. Stavric B. Role of chemopreventers in human diet. Clin. Biochem. 27:1994;319-332.
6. Ip C., Lisk D.J., Scimeca J.A. Potential of food modification in cancer prevention. Cancer Res. 54 (Suppl.):1994;1957s-1959s.
7. Greenwald P., Kelloff G.J., Boone C.W., McDonald S.S. Genetic and cellular changes in colorectal cancer: proposed targets of chemopreventive agents. Cancer Epidemiol. Biomarkers Prev. 4:1995;691-702.
8. Takahashi M., Minamoto T., Yamashita N., Kato T., Yazawa K., Esumi H. Effect of docosahexaenoic acid on azoxymethane-induced colon carcinogenesis in rats. Cancer Lett. 83:1994;177-184.
9. Takahashi M., Minamoto T., Yamashita N., Yazawa K., Sugimura T., Esumi H. Reduction in formation and growth of 1,2-dimethylhydrazine-induced aberrant crypt foci in rat colon by docosahexanoic acid. Cancer Res. 53:1993;2786-2789.
10. Reddy B.S., Sugie S. Effect of different levels of omega-3 and omega-6 fatty acids on azoxymethane-induced colon carcinogenesis in F344 rats. Cancer Res. 48:1988;6642-6647.
11. Weisburger J.H., Braley J., Reinhardt J., Aliaga C., Rivenson A., Hard G.C., Zhang X-M., Takahashi M., Esumi H., Sugimura T. The role of fat and calcium in the production of foci of aberrant crypts in the colon of rats fed 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine. Environ. Health Perspect. 102 (Suppl. 6):1994;53-55.
12. Reddy B.S., Sugie S., Maruyama H., El-Bayoumy K., Marra P. Chemoprevention of colon carcinogenesis by dietary organoselenium, benzylselenocyanate, in F344 rats. Cancer Res. 47:1987;5901-5904.
13. Reddy B.S., Nayini J., Tokumo K., Rigotty J., Zang E., Kelloff G. Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a non-steroidal anti-inflammatory drug with D,L-α-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet. Cancer Res. 50:1990;2562-2568.
14. Reddy B.S., Tokumo K., Kulkarni N., Aligia C., Kelloff G. Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds. Carcinogenesis. 13:1992;1019-1023.
15. Reddy B.S., Maruyama H., Kelloff G. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a non-steroidal anti-inflammatory drug, during different stages of rat colon tumor development. Cancer Res. 47:1987;5340-5346.
16. Thun M., Namboordiri M., Heath C. Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med. 325:1991;1593-1596.
17. Rao C.V., Rivenson A., Simi B., Zang E., Kelloff G., Steele V., Reddy B.S. Chemoprevention of colon carcinogenesis by sulindac, a non-steroidal anti-inflammatory agent. Cancer Res. 55:1995;1464-1472.
18. Narisawa T., Sato M., Tani M., Kudo T., Takahashi T., Goto A. Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment. Cancer Res. 41:1981;1954-1957.
19. Labayle D., Boyer J., Drouhin F., Zarka Y., Fischer F. Sulindac in familial adenomatous polyposis. Lancet. 343:1994;417-418.
20. Labayle D., Fischer D., Vielh P., Drouhin F., Pariente A., Bories C., Duhamel O., Trousset M., Attali P. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology. 101:1991;635-639.
21. Trujillo M.A., Garewal H.S., Sampliner R.E. Non-steroidal anti-inflammatory agents in chemoprevention of colorectal cancer. At what cost? Dig. Dis. Sci. 39:1994;2260-2266.
22. Ozaki Y. Studies on anti-inflammatory effect of Japanese oriental medicines (Kampo medicines) used to treat inflammatory diseases. Biol. Pharm. Bull. 18:1995;559-562.
23. Chan K. Progress in traditional Chinese medicine. Trends Pharmacol. Sci. 16:1995;182-187.
24. Okita K., Li Q., Murakamio T., Takahashi M. Anti-growth effects with components of Sho-saiko-to (TJ-9) on cultured human hepatoma cells. Eur. J. Cancer Prev. 2:1993;169-176.
25. 1 phase. Cancer Res. 54:1994;448-454.
26. Fukutake M., Yokota S., Kawamura H., Iizuka A., Amagaya S., Fukuda K., Komatsu Y. Inhibitory effect of Coptidis rhizoma and Scutellariae radix on azoxymethane-induced aberrant crypt foci formation in rat colon. Biol. Pharm. Bull. 21:1998;814-817.
27. Bird R.P. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 37:1987;147-151.
28. Ip C., Ganther H.E. Combination of blocking agents and suppressing agents in cancer prevention. Carcinogenesis. 12:1991;365-367.
29. Morse M.A., Stoner G.D. Cancer chemoprevention: principles and prospects. Carcinogenesis. 14:1993;1737-1746.
30. Nakatsugi S., Terada N., Yoshimura T., Horie Y., Furukawa M. Effects of nimesulide, a preferential cyclooxygenase-2 inhibitor, on carrageenan-induced pleurisy and stress-induced gastric lesions in rats. Prostaglandins Leukotrienes Essent. Fatty Acids. 55:1996;395-402.
31. Nakatsugi S., Fukutake M., Takahashi M., Fukuda K., Isoi T., Taniguchi Y., Sugimura T., Wakabayashi K. Suppression of intestinal polyp development by nimesulide, a selective cyclooxygenase-2 inhibitor, in Min mice. Jpn. J. Cancer Res. 88:1997;1117-1120.
32. Fukutake M., Nakatsugi S., Isoi T., Takahashi M., Ohta T., Mamiya S., Taniguchi Y., Sato H., Fukuda K., Sugimura T., Wakabayashi K. Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice. Carcinogenesis. 19:1998;1939-1942.
33. Murakoshi M., Nishino H., Satomi Y., Takayasu J., Hasegawa T., Tokuda H., Iwashima A., Okuzumi J., Okabe H., Kitano H., Okabe H., Iwasaki R. Potent preventive action of alpha-carotene against carcinogenesis: spontaneous liver carcinogenesis and promoting stage of lung and skin carcinogenesis in mice are suppressed more effectively by alpha-carotene than by beta-carotene. Cancer Res. 52:1992;6583-6587.
34. Nishino H. Cancer chemoprevention by natural carotenoids and their related compounds. J. Cell Biochem. 22:1995;231-235.